TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol

BACKGROUND: Pneumonia is the most frequent complication of COVID-19, due to an aberrant host immune response that is associated with an acute respiratory distress syndrome, and, in most critical patients, with a “cytokine storm”. IL-6 might play a key role in the cytokine storm and might be a potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccirillo, Maria Carmela, Ascierto, Paolo, Atripaldi, Luigi, Cascella, Marco, Costantini, Massimo, Dolci, Giovanni, Facciolongo, Nicola, Fraganza, Fiorentino, Marata, AnnaMaria, Massari, Marco, Montesarchio, Vincenzo, Mussini, Cristina, Negri, Emanuele Alberto, Parrella, Roberto, Popoli, Patrizia, Botti, Gerardo, Arenare, Laura, Chiodini, Paolo, Gallo, Ciro, Salvarani, Carlo, Perrone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536129/
https://www.ncbi.nlm.nih.gov/pubmed/33031955
http://dx.doi.org/10.1016/j.cct.2020.106165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536129/
https://www.ncbi.nlm.nih.gov/pubmed/33031955
http://dx.doi.org/10.1016/j.cct.2020.106165

Ejemplares similares